![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 33, 31007-31019, August 15, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the
Scripps Research Institute, Departments of Molecular Biology and
Molecular and Experimental Medicine, La Jolla, California 92037 and
The Wellcome Trust Biocentre, School of Life
Sciences, University of Dundee, Dundee DD15EH, Scotland, United Kingdom
Ten of the 11 known human siglecs or their murine orthologs have been
evaluated for their specificity for over 25 synthetic sialosides representing
most of the major sequences terminating carbohydrate groups of glycoproteins
and glycolipids. Analysis has been performed using a novel multivalent
platform comprising biotinylated sialosides bound to a streptavidin-alkaline
phosphatase conjugate. Each siglec was found to have a unique specificity for
binding 16 different sialoside-streptavidin-alkaline phosphatase probes. The
relative affinities of monovalent sialosides were assessed for each siglec in
competitive inhibition studies. The quantitative data obtained allows a
detailed analysis of each siglec for the relative importance of sialic acid
and the penultimate oligosaccharide sequence on binding affinity and
specificity. Most remarkable was the finding that myelin-associated
glycoprotein (Siglec-4) binds with 50010,000-fold higher affinity to a
series of mono- and di-sialylated derivatives of the O-linked
T-antigen (Gal
(13)-GalNAc
OThr) as compared with
-methyl-NeuAc.
Received for publication, April 25, 2003 , and in revised form, May 27, 2003.
* This work was supported in part by United States Public Health Service Grants GM60938 (to J. C. P.) and GM25042 (to B. E. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by The Swedish Institute.
¶ To whom correspondence should be addressed: Depts. of Molecular Biology and Molecular and Experimental Medicine, MEM-L71, 10550 North Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-784-9634; Fax: 858-784-9690; E-mail: jpaulson{at}scripps.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
B. J. Swanson, K. M. McDermott, P. K. Singh, J. P. Eggers, P. R. Crocker, and M. A. Hollingsworth MUC1 Is a Counter-Receptor for Myelin-Associated Glycoprotein (Siglec-4a) and Their Interaction Contributes to Adhesion in Pancreatic Cancer Perineural Invasion Cancer Res., November 1, 2007; 67(21): 10222 - 10229. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Naito, H. Takematsu, S. Koyama, S. Miyake, H. Yamamoto, R. Fujinawa, M. Sugai, Y. Okuno, G. Tsujimoto, T. Yamaji, et al. Germinal Center Marker GL7 Probes Activation-Dependent Repression of N-Glycolylneuraminic Acid, a Sialic Acid Species Involved in the Negative Modulation of B-Cell Activation Mol. Cell. Biol., April 15, 2007; 27(8): 3008 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nasirikenari, B. H. Segal, J. R. Ostberg, A. Urbasic, and J. T. Lau Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I Blood, November 15, 2006; 108(10): 3397 - 3405. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Attrill, A. Imamura, R. S. Sharma, M. Kiso, P. R. Crocker, and D. M. F. van Aalten Siglec-7 Undergoes a Major Conformational Change When Complexed with the {alpha}(2,8)-Disialylganglioside GT1b J. Biol. Chem., October 27, 2006; 281(43): 32774 - 32783. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Avril, S. J. North, S. M. Haslam, H. J. Willison, and P. R. Crocker Probing the cis interactions of the inhibitory receptor Siglec-7 with {alpha}2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of {alpha}2,8-sialyltransferase gene expression J. Leukoc. Biol., October 1, 2006; 80(4): 787 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Collins, O. Blixt, S. Han, B. Duong, H. Li, J. K. Nathan, N. Bovin, and J. C. Paulson High-Affinity Ligand Probes of CD22 Overcome the Threshold Set by cis Ligands to Allow for Binding, Endocytosis, and Killing of B Cells. J. Immunol., September 1, 2006; 177(5): 2994 - 3003. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Comelli, M. Sutton-Smith, Q. Yan, M. Amado, M. Panico, T. Gilmartin, T. Whisenant, C. M. Lanigan, S. R. Head, D. Goldberg, et al. Activation of Murine CD4+ and CD8+ T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans J. Immunol., August 15, 2006; 177(4): 2431 - 2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Avril, E. R. Wagner, H. J. Willison, and P. R. Crocker Sialic Acid-Binding Immunoglobulin-Like Lectin 7 Mediates Selective Recognition of Sialylated Glycans Expressed on Campylobacter jejuni Lipooligosaccharides Infect. Immun., July 1, 2006; 74(7): 4133 - 4141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. von Gunten and H.-U. Simon Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes FASEB J, April 1, 2006; 20(6): 601 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varki and T. Angata Siglecs--the major subfamily of I-type lectins Glycobiology, January 1, 2006; 16(1): 1R - 27R. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tateno, P. R. Crocker, and J. C. Paulson Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand Glycobiology, November 1, 2005; 15(11): 1125 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Vyas, O. Blixt, J. C. Paulson, and R. L. Schnaar Potent Glycan Inhibitors of Myelin-associated Glycoprotein Enhance Axon Outgrowth in Vitro J. Biol. Chem., April 22, 2005; 280(16): 16305 - 16310. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Bochner, R. A. Alvarez, P. Mehta, N. V. Bovin, O. Blixt, J. R. White, and R. L. Schnaar Glycan Array Screening Reveals a Candidate Ligand for Siglec-8 J. Biol. Chem., February 11, 2005; 280(6): 4307 - 4312. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Blixt, S. Head, T. Mondala, C. Scanlan, M. E. Huflejt, R. Alvarez, M. C. Bryan, F. Fazio, D. Calarese, J. Stevens, et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins PNAS, December 7, 2004; 101(49): 17033 - 17038. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Avril, H. Floyd, F. Lopez, E. Vivier, and P. R. Crocker The Membrane-Proximal Immunoreceptor Tyrosine-Based Inhibitory Motif Is Critical for the Inhibitory Signaling Mediated by Siglecs-7 and -9, CD33-Related Siglecs Expressed on Human Monocytes and NK Cells J. Immunol., December 1, 2004; 173(11): 6841 - 6849. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikehara, S. K. Ikehara, and J. C. Paulson Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9 J. Biol. Chem., October 8, 2004; 279(41): 43117 - 43125. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Collins, O. Blixt, A. R. DeSieno, N. Bovin, J. D. Marth, and J. C. Paulson Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact PNAS, April 20, 2004; 101(16): 6104 - 6109. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Sonnenburg, T. K. Altheide, and A. Varki A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor Glycobiology, April 1, 2004; 14(4): 339 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xia, T. Ju, A. Westmuckett, G. An, L. Ivanciu, J. M. McDaniel, F. Lupu, R. D. Cummings, and R. P. McEver Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans J. Cell Biol., February 2, 2004; 164(3): 451 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-P. Danzer, B. E. Collins, O. Blixt, J. C. Paulson, and L. Nitschke Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling Int. Immunol., October 1, 2003; 15(10): 1137 - 1147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |